Celularity Analyst Ratings
Celularity Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/12/2022 | 103.25% | Morgan Stanley | $8 → $5 | Maintains | Equal-Weight |
| 08/25/2022 | 509.76% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 143.9% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 509.76% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 265.85% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 265.85% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 387.8% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 09/12/2022 | 103.25% | 摩根士丹利 | 8 美元 → 5 美元 | 维护 | 重量相等 |
| 08/25/2022 | 509.76% | 联盟全球合作伙伴 | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 2022 年 8 月 23 日 | 143.9% | 信实证券 | 10 美元 → 6 美元 | 维护 | 保持 |
| 06/22/2022 | 509.76% | HC Wainwright & Co. | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 04/06/2022 | — | 信实证券 | 降级 | 买入 → 持有 | |
| 01/28/2022 | 265.85% | 奥本海默 | → 9 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 11/24/2021 | 265.85% | 摩根士丹利 | → 9 美元 | 启动覆盖范围开启 | → 重量相等 |
| 10/19/2021 | 387.8% | 信实证券 | → 12 美元 | 启动覆盖范围开启 | → 购买 |
Celularity Questions & Answers
Cellarity 问题与解答
The latest price target for Celularity (NASDAQ: CELU) was reported by Morgan Stanley on September 12, 2022. The analyst firm set a price target for $5.00 expecting CELU to rise to within 12 months (a possible 103.25% upside). 8 analyst firms have reported ratings in the last year.
摩根士丹利于2022年9月12日公布了Celularity（纳斯达克股票代码：CELU）的最新目标股价。该分析公司将目标股价定为5.00美元，预计CELU将在12个月内升至12个月内（可能上涨103.25％）。去年有8家分析公司公布了评级。
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by Morgan Stanley, and Celularity maintained their equal-weight rating.
摩根士丹利对Celularity（纳斯达克股票代码：CELU）的最新分析师评级由摩根士丹利提供，Celularity维持同等权重评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on September 12, 2022 so you should expect the next rating to be made available sometime around September 12, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Celularity的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Celularity的最新评级是在2022年9月12日发布的，因此您应该预计下一个评级将在2023年9月12日左右公布。
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $8.00 to $5.00. The current price Celularity (CELU) is trading at is $2.46, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Celularity（CELU）评级保持不变，目标股价为8.00美元至5.00美元。Celularity（CELU）目前的交易价格为2.46美元，超出了分析师的预期区间。